Goo obtained an M.P.H. in epidemiology and international health at the University of Michigan, followed by a Ph.D. at the University of Washington’s Pathobiology Program, where she focused on the development of neutralizing antibodies and their role in preventing HIV transmission. As a postdoctoral fellow at NIH/NIAID, Goo studied the molecular and structural determinants of antibody recognition of flaviviruses and alphaviruses. At CZ Biohub, her research focused on deconstructing the polyclonal antibody response to antigenically diverse viruses. Goo’s overall goal was to inform immunogen design and vaccination strategies by understanding the mechanisms and outcomes of virus-antibody interactions.